Konrad Dobschuetz

Founder Director at Leap Advisory & Intelligence

London Area, United Kingdom

About me

Konrad Dobschütz is a recognised global leader in health. He can provide over 20 years of commercial innovation expertise from founding his own business to working as National Director in the NHS and for multinationals such as Pfizer and Novartis. In his role as Director at Leap Advisory & Intelligence, he supports MedTech and Digital Health companies in their go-to-market, investment, and partnership efforts across the US, UK, and other markets. He also works with the UK Foreign Office on start-up initiatives to attract companies to the UK, while also sitting on the board of companies in the longevity space.

Schedule

Welcome Address & Chairperson’s Opening Remarks

Begin your conference journey with a warm welcome from our esteemed Chairperson

Konrad Dobschuetz

Founder Director at Leap Advisory & Intelligence

Wednesday - May 27, 2026 |
04:10 PM - 04:45 PM |
35 Minutes

Panel Discussion: AI and Automation in Drug Discovery: From Hype to Real-World Breakthroughs – Can Innovation Keep Up with Regulation?

How close are we to AI-designed drugs reaching patients — and what’s still missing in validation and translation?
Are global frameworks agile enough to assess and approve discoveries driven by algorithms?
What real-world examples reveal the difference between AI hype and genuine productivity gains in discovery?
When AI suggests a molecule or pathway, who takes responsibility if it fails — the scientist, the system, or the sponsor?
How will AI, quantum computing, and automation converge to redefine timelines, talent, and trust in the pharma R&D ecosystem?